Multiple system atrophy (MSA) is a rare disorder with limited treatment options. However, recent research has yielded promising insights into new therapeutic approaches. Current focus centers on targeting the underlying pathophysiology of MSA. One avenue under investigation involves pharmacological interventions to regulate the dysregulation of sp